IL6 and Sepsis: Treatment of mice with general S1PR agonist FTY720 and S1P lyase inhibitor 4-deoxypyridoxine before inducing sepsis by peritoneal contamination and infection (PCI) reduced microvascular leakage in lung and liver, and dampened IL-6, TNFα, and MCP-1 production.